Preliminary experiments show conolidine may inhibit particular ion channels, cutting down neuronal excitability and restricting discomfort alerts. This system is particularly appropriate in neuropathic soreness, in which irregular signaling triggers persistent soreness. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to soreness percept... https://harryp627izq3.wikilowdown.com/user